Point-of-care testing in the community pharmacy

Pharmaceutical Journal

Volumn 267, Issue 7162, 2001, Pages 267-268

  Moffat, Tony ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006465218     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Department of Health. Pharmacy in the future - Implementing the NHS Plan. London: Department of Health; 2000.
2. Pharmacist asthma referral project starts in London. Pharm J 1996; 256:540.
3. Mackie C. Asthma clinic. Chemist & Druggist 1996;246:III-VI.
4. Study to look at asthma monitoring by community pharmacists. Pharm J 2000; 264: 281.
5. A chronic obstructive pulmonary disease clinic. Pharm J 1998;261:26.
6. Moorhouse GE, Brown WJD, Edwards C. A pharmacist managed H pylori eradication programme in general practice. Pharm J 1996;257 (Suppl):R5.
7. Hawksworth GM, Chrystyn H. Therapeutic drug and biochemical monitoring in a community pharmacy: Part 1. Int J Pharm Pract 1995;3:133-8.
8. Testing times. Chemist & Druggist 2000;254:19-26.
9. Royal Pharmaceutical Society of Great Britain. Medicines, Ethics and Practice - A Guide for Pharmacists, 25th edition. London: The Society; 2001. p90.
10. Moffat AC, Dawson W. Pharmacogenomics: a new opportunity for pharmacists. London: Royal Pharmaceutical Society of Great Britain; 2000.